Hopes Rise For SK’s COVID-19 Vaccine As It Moves To Comparative Phase III Trial

Korean Candidate A Global Contender?

SK Bioscience R&D
SK’s COVID-19 Vaccine Developed With Unprecedented Global Support • Source: SK Bioscience

More from South Korea

More from Focus On Asia